Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Acumen Pharmaceuticals, Inc./ 10-Q

Quarterly Report · 10-Q

Acumen Pharmaceuticals, Inc.

ABOSNASDAQEQUITYCurrent

Quarterly Report

Filed May 12, 2026Accepted May 12, 2026, 5:16 PM EDTCIK 1576885Accession 0001628280-26-034204
View company →Permanent SEC source ↗
Share

Company context

Current securities

ABOSNASDAQ · EQUITY · Current

Recent company filings

  1. Regulation FD DisclosureSep 16, 2026
  2. S-8 filingAug 12, 2026
  3. 10-Q filingAug 12, 2026
  4. Results of Operations and Financial Condition · Regulation FD DisclosureAug 12, 2026
  5. Regulation FD Disclosure · Other EventsJun 16, 2026

As-filed source

Primary evidence
As filedOpen full document ↗